3M is a global diversified technology company with a market presence in six business segments: Health Care; Industrial and Transportation; Display and Graphics; Consumer and Office; Safety, Security and Protection Services; and Electro and Communications. The company has operations in more than 60 countries and its products are sold in nearly 200 countries worldwide. The group employs more than 80,000 people worldwide.
The Health Care division serves markets that include medical clinics and hospitals, pharmaceuticals, dental and orthodontic practitioners, and health information systems. Products and services provided to these and other markets include medical and surgical supplies, skin health and infection prevention products, inhalation and transdermal drug-delivery systems, dental and orthodontic products, food safety products and health information systems.
At the time of writing, 3M Health Care operated through the following lines of business
- Medical: Infection Prevention
- Medical: Skin and Wound Care
- 3M Littmann Stethoscopes
- Medical Supplies & OEM Products
- Health Information Systems
- Oral Care: Dental (3M ESPE)
- Oral Care: Orthodontics (3M Unitek)
- Food Safety (Microbiology)
- Drug Delivery Systems
- Veterinary Products (Animal Care).
This report does not include details on 3M’s Food Safety and Veterinary operations.
In the year ended 31st December 2011, 3M Health Care reported sales of US$5,031 million, which represented 17% of the 3M group’s total revenue.
3M’s competitors in the wound care market include Smith & Nephew, Kinetic Concepts, ConvaTec and Coloplast. In the health information systems market, 3M’s principal rivals are Agfa, GE Healthcare, Siemens and Philips. In the dental and orthodontic sector, 3M competes with Prestige Dental, Kerr Dentistry, Dentsply and Patterson Dental. In the drug-delivery market, Respironics and Novosis are the main competitors faced by 3M.
Published: May 2012 No. of Pages: 60 Price: US $ 515
This company report provides
Overview
- Key contact information
- Introduction to the company and its current activities
- Summary of its financial performance
- Who are the company’s major competitors?
- Key recent events in an “at a glance” format
Financial Review
- Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
- Table providing in-depth five-year financial analysis
- Employee data, including breakdown by company division and geographic location
Strategic Focus
Investigates the company’s aims and its areas of focus
Products
Core product areas, key brands, product approvals and launches
Research and Development
- How much has been invested in R&D?
- Where is the research based?
- What alliances and agreements does the company have and with whom?
Manufacturing and Distribution
- Identifying the company’s manufacturing locations
- Sales and marketing facilities
Agreements
- With whom has the company reached agreements and what do they involve?
- Key contracts awarded
Mergers, Acquisitions, Minority Investments and Divestments
Litigation
Key Corporate Events
Table Of contents
OVERVIEW 1
FINANCIAL REVIEW 2
First Quarter 2012 Financial Results.2
3M Health Care3
2011 Financial Results3
3M Health Care4
Five-Year Financial Data6
Outlook7
STRATEGIC FOCUS 8
PRODUCTS 9
Dental Products.10
Recent Product Developments10
Lava Ultimate CAD/CAM Restorative . 11
Scotchbond Universal Adhesive 11
Impregum and Imprint 3 Intra-Oral Syringes 11
Orthodontic Products.12
Recent Product Developments 12
Unitek TMP.12
Incognito Lite Hidden Braces12
Medical Supplies13
Infection Prevention. 13
Stethoscopes 14
Temperature Management Systems 15
Skin and Wound Care15
Recent Product Developments15
Medical Specialities and OEM Products.16
Drug-Delivery Systems.17
Inhalation Drug-Delivery. 17
Dry-Powder Inhaler.17
Pressurised Metered Dose Inhalers17
Integrated Dose By Dose Counter17
Breath Actuated Inhaler System18
Nasal MDI18
Components: Valves & Canisters18
Transdermal and Microneedle 18
3M Passive Transdermal Technology.18
3M Microneedle Technology18
3M Health Information Systems.19
Recent Product Developments21
360 Encompass System21
RESEARCH AND DEVELOPMENT 23
Research Establishments.23
R&D Studies & Trials23
Drug-Delivery23
Conix Dry-Powder Inhaler23
Infection Prevention.24
Avagard24
DuraPrep Surgical Solution 24
Research Agreements.25
Celldex Therapeutics/AVANT Immunotherapeutics25
Response Biomedical26
Sepracor (Sunovion)26
MicroDose Therapeutx26
Chiesi Farmaceutici.27
Novartis Pharma.27
Dolphin Imaging & Management Solutions.27
MANUFACTURING 28
AGREEMENTS. 29
Medical Supplies. 31
RL Solutions 31
Sage Products31
Medline Industries31
Patient Care Technology Systems32
TSO3 32
Zargis Medical .32
Med-Tech Associates and Med-Care Associates33
Response Biomedical33
Drug Delivery Systems. 33
Radius Health 33
Spirig Pharma34
VaxInnate34
Cambridge Consultants.34
Infectious Disease Research Institute.35
Forest Laboratories.35
Skin and Wound Care. 35
Kinetic Concepts.35
Greystone Pharmaceuticals35
ClozeX Medical.36
Advanced Medical Solutions.36
Health Information Systems. 36
SourceHOV/LexiCode36
Clinical Architecture .36
University HealthSystem Consortium.37
Nuance Communications.37
HealthTrust Purchasing Group38
VHA38
IQMax39
Amerinet39
CitiusTech39
Siemens Medical Systems.40
HealthShare Technology (WebMD)40
HealthGrades.40
CareAdvantage40
LanVision Systems/Streamline Health41
Noteworthy Medical Systems41
Meta Health Technology41
Outcome Concept Systems.41
Fazzi Associates42
Sentillion42
AutoData Systems42
MedicaLogic42
Dental and Orthodontics 43
Zirkonzahn .43
Straumann43
Biomet 3i 44
Jensen Dental. 44
Ceradyne 44
MERGERS AND ACQUISITIONS. 45
CodeRyte 46
Zargis Medical Assets 46
Arizant. 46
Hangzhou ORJ Medical Instrument and Material47
J.R. Phoenix.47
ACE Product Line from BD.47
TOP-Service für Lingualtechnik.47
IMTEC Corporation47
Les Entreprises Solumed47
Lingualcare 48
Abzil Industria e Comercio. 48
Neoplast Company. 48
Articulos de Papel DMS Chile49
Acolyte Biomedica49
SoftMed Systems49
Biotrace International50
Brontes Technologies50
SBG (Software und Beratung im Gesundheitswesen).50
OMNII Oral Pharmaceuticals.50
ClozeX Medical.51
Info-X.51
Vantage Health’s Medical Record Coding Software.51
3M Inter-Unitek and ESPE Dental51
Ruffing IT51
NAMSA’s Rapid Sterilisation Indicator Product Line.51
Hyatt, Imler, Ott and Blount52
PACE Health Management Systems52
Datacron.52
Health Market International’s Software Products52
PyMaH52
MINORITY INVESTMENTS 53
Zephyr Technology53
Response Biomedical53
MicroDose Technologies53
DIVESTITURES 54
3M Pharmaceuticals54
3M Powered Surgical Instrument Business54
3M Orthopaedic Implant Business.54
3M CardioVascular Systems54
Imation.54
Internal Stapling Business54
Diagnostics Systems Unit.54
Multi-lumen Catheter Product Line55
Cochlea Implants Business.55
Hip and Shoulder Implant Business55
LITIGATION 56
Investors in Acolyte.56
Zirkonzahn .56
Porton Capital Technology Funds and UK Ministry of Defence.57
Ivoclar Vivadent57
Universal Medical Distributors58
Andover Healthcare58
Pradeep Mohan58
KEY CORPORATE EVENTS 59
List of Tables
SUMMARY OPERATING RESULTS.iii
Recent Key Events.1
3M Company – First Quarter 2012 Financial Results.2
3M – First Quarter 2012 Financial Results by Business Sector2
3M Company – Annual Financial Results, 2007-2011.3
3M Company – Annual Financial Results by Business Sector, 2008-2011.3
3M Health Care – Annual Financial Results, 2007-2011.4
List of Charts
3M – Annual Sales by Business Sector, 2008-2011.4
(US$ million)4
3M Health Care – Annual Sales and Operating Income, 2007-20115
3M Health Care – 2010 Sales by Product Area 9